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Abstract
Placebos are medical interventions that falsely lead 
patients to believe that they are receiving treatment and 
that their condition is being changed, when truly no 
specific treatment is being administered.  Using 
placebos in research involving terminal illnesses has 
become debatable. While a placebo could potentially 
give way to new treatments, through testing alongside a 
specific drug in a clinical trial, the placebo itself may 
fail and the patient is not cured leading to possible 
fatality. It has been found that using placebos in 
research, like performing surgeries, can aid in medical 
or clinical research and could help our society 
financially by discouraging unnecessary operations. On 
the other hand, there are also risks involved, including 
the health risks that may result from the placebo-
controlled trial, and most importantly the justification 
and ethics of using placebos on patients without their 
consent. While evaluating several studies involving 
placebo-induced treatments, we have discovered 
methods in which placebos can help society; although 
these helpful means can also raise issues regarding 
one’s ethics. Using placebos in treatments will not 
necessarily treat the illness itself, but they can be 
beneficial towards research in discovering new 
treatments for terminal illnesses. 
Ethical Question
Is it ethical to use placebos in research involving 
terminal illnesses? Is it ethical to use placebos on
patients who believe that they are really being treated for 
their illness?
Introduction
The use of placebos in research involving terminal 
illnesses is debatable. There are possible benefits to
performing placebo-controlled trials.  However, the
ethics of using placebos on patients without their 
consent  is what  drives our ethical question.
Discussion
Placebos have helped patients make full recoveries from 
their terminal illness on their own until the patients are told 
that the treatment they received is not the drug they were 
told that they were receiving. In one particular case the 
treatment failed and the patient had a relapse after reading 
an article about the ineffective drug, and the patient became 
more sick than before the treatment had taken place. This 
particular case involved the trial-stage cancer drug called 
Krebiozen. Krebiozen was a drug that was supposed to be 
the end to cancer, but this was not the case. The drug never 
got approved and instead was less effective than the placebo 
given in the double blind trial (The Placebo Effect). The 
reason that the Krebiozen placebo helped the patient get 
better was because of the mental effect that taking a drug to 
cure them was working and their mind telling their body 
that this will help it so it did, though it only worked because 
the patient believed it would. This shows how the mind can 
effect the body in more ways then one. The placebo itself 
can be used to help the human but at the same time it can 
hurt since placebos fool the mind into thinking that the body 
is receiving treatment and the patient will feel fine but in 
truth the body isn’t fine at all. The placebo is just tricking 
the brain into easing the pain naturally so that the patient 
won’t feel it and think that they are cured. 
Another point is that Placebo-controlled trials can hinder 
the research and treatment of terminal illnesses. For 
example, one article claims that the rigorous drug trials 
administered by the Food and Drug Administration deny 
patients with cancer from getting access to potentially 
lifesaving drugs. One of the ways the FDA prohibits cancer 
patients from receiving potential life-saving vaccines, is 
through the increasing requirement for companies to hold 
randomized and placebo-controlled trials with new cancer 
treatments. The potential health risks and mainly the ethics 
of using placebos on patients makes placebo research 
debatable (FDA Rules Hinder Cancer Vaccines).
Conclusion
The use of placebos is mainly just a way 
of psychological treatment. Placebo 
treatment does not treat the illness itself. 
Performing placebo-controlled trials on 
patients is unethical if they are not 
informed and have not given their 
consent. Even if the patient is terminally 
ill, they should have the right to know 
exactly how they are being treated.    
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Analysis
The two topics that have been discussed here  
illustrate the ethics of Placebo research in 
terminal illnesses. In The Placebo Effect the 
patient had a full recovery from being told that 
the medicine given to them would help them 
fully recover. This can be ethical in some ways 
but it mostly isn’t ethical at all because telling 
the patient that the placebo will help them get 
better is false because it truly has no actual 
medical effects. Their condition goes back to the 
way it was and will eventually lead to death. 
The other topic demonstrates how having a 
placebo can hinder the treatment of terminal 
illness which in turn can hurt the patient even 
more than it already has and the patient can no 
longer be helped and will be forced to wait for 
the inevitable untreated because of specific 
guidelines that must be followed.
Fig. 1. Arguriou, Peter. The Placebo Effect -
The Triumph of Mind over Body.
